Factors Leading to Diabetes in Prediabetic Patients
Study of the Factors Favoring the Transition From Prediabetes to Diabetes on Reunion Island.
Recruiting
N/AInterventional Study
Diabetes
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
25 – 70
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
2,000 (estimated)
Sponsor
Centre Hospitalier Universitaire de la Réunion · Other
Who this trial is looking for
This trial is looking for adults with prediabetes to help understand why some people progress to diabetes. Participants will be asked to answer a telephone questionnaire and have their blood sugar levels tested.
Are You a Good Fit for This Trial?
You may be able to join if
I am aged between 25 and 70 years old.
I have prediabetes with specific blood sugar levels.
I can answer a telephone survey.
I have never been diagnosed or treated for diabetes, except gestational diabetes.
I have social security coverage.
I can provide signed consent to participate.
You may not be able to join if
I plan to leave Reunion Island within 2 years.
I am under guardianship or similar legal protection.
I have serious physical or mental health issues affecting my study participation.
I am currently pregnant.
I am participating in another research study.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
The management of diabetes and its complications in Reunion island is one of the priority areas of health. Indeed, the impact of diabetes on the health of the Reunion island population is major: the prevalence of diabetes treated in Reunion island is the highest in France (10% of the population), and gestational diabetes is found in 10% of pregnancies. Reunionese diabetics develop severe complicat…
The management of diabetes and its complications in Reunion island is one of the priority areas of health. Indeed, the impact of diabetes on the health of the Reunion island population is major: the prevalence of diabetes treated in Reunion island is the highest in France (10% of the population), and gestational diabetes is found in 10% of pregnancies. Reunionese diabetics develop severe complications, in particular cardiovascular (strokes, myocardial infarction).
This results in 3 times higher mortality linked to diabetes on Reunion Island, in particular among those under 65 years of age. Despite all the screening and prevention programs put in place, the weight of diabetic disease continues to increase in our island, and this is more accelerated than in the other French departments with 4,300 new cases of diabetes / year, 95% of which type 2 diabetics (T2D). The presentation of type 2 diabetic patients in Reunion island also differs from the Metropolis with subjects more often female (56%), thinner and younger at the discovery of diabetes. These data highlight the need to better understand the factors underlying the diabetes "epidemic" in Reunion island.
The rise in blood sugar until the onset of diabetes is a continuous phenomenon reflecting the progressive suffering of the organs used to maintain carbohydrate homeostasis. Thus, we talk about fasting hyperglycemia when the fasting blood sugar is between 1.10 and 1.25 g / L (6.1-6.9 mmol / l) and glucose intolerance when the blood sugar 2 hours after taking 75 g of glucose is between 1.40 and 1.99 g / L (7.8-11.0 mmol / l). Subjects with fasting hyperglycemia or glucose intolerance constitute the target population at very high risk of developing diabetes (up to 70% of these subjects). They have an increased risk of developing diabetes at 1 year multiplied by 5 to 10 compared to normoglycemic subjects, hence the name "prediabetic subjects". This great variability in the risk of developing diabetes highlights the presence of associated risk / protective factors which it is important to find in order to adapt the monitoring and management. It is important in Reunion island, in view of the specificities presented by our population, to understand the pre-diabetes / diabetes transition and the risk and protective factors.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Subject aged 25 to 70 with pre-diabetes defined by fasting blood sugar between 1.10 and 1.25 g / l (6.1 and 6.9 mmol / l) or blood sugar between 1.40 and 1.99 g / l (7.8 and 11.0 mmol / l) 2 hours after taking 75g of glucose (HGPO test), dating from less than 3 months.
* Consu…
Inclusion Criteria:
* Subject aged 25 to 70 with pre-diabetes defined by fasting blood sugar between 1.10 and 1.25 g / l (6.1 and 6.9 mmol / l) or blood sugar between 1.40 and 1.99 g / l (7.8 and 11.0 mmol / l) 2 hours after taking 75g of glucose (HGPO test), dating from less than 3 months.
* Consulting one of the general practitioners involved in the study, whatever the initial reason for the consultation
* able to answer a telephone survey questionnaire
* who have never been diagnosed or treated for diabetes with the exception of gestational diabetes
* Person affiliated or beneficiary of a social security scheme.
* Free, informed and written consent signed
Exclusion Criteria:
* People likely to leave Reunion within 2 years
* Persons placed under guardianship, curators, safeguard of justice, person participating in another research including an exclusion period still in progress.
* Person with severely impaired physical and / or psychological health, who, according to the investigator, may affect the compliance of the study participant.
* Pregnancy in progress
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.